Bruker Corporation announced a major technological breakthrough in the CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the CellScape platform has...
Bruker Corporation launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well...
At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The rapid advances in deep,...
At the SLAS2024 International Conference and Exhibition, Bruker Corporation introduced the ground-breaking, new ‘Triceratops’ SPR #64Surface Plasmon Resonance (SPR) instrument. The SPR #64 system has been engineered from...
At the Experimental Nuclear Magnetic Resonance Conference, Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural...
